Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia
Clinical Gastroenterology and Hepatology · 2023
DOI: 10.1016/j.cgh.2023.02.001 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023. Verfasst von Alexander C Ford und 1 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, United Kingdom; and, Leeds Institute of Medical Research at St. James's, Un…. Hauptthemen laut MEDLINE: Dyspepsia, Anti-Ulcer Agents, Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, United Kingdom; and, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, United Kingdom.
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Tennessee College of Medicine, Memphis, Tennessee.
Zitieren
APA
Ford, A. C., & Howden, C. W. (2023). Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.02.001
Vancouver
Ford AC, Howden CW. Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia. Clinical Gastroenterology and Hepatology. 2023. doi:10.1016/j.cgh.2023.02.001
BibTeX
@article{Ford2023,
author = {Ford, Alexander C and Howden, Colin W},
title = {Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
doi = {10.1016/j.cgh.2023.02.001}
}
EUVIMED